Top-line results show some hope for treatment even though a research goal was missed.
The ECB is considering yield band targets for a new bond-buying program. Orders for US durable goods jump, but the core number slides. Fed stimulus hopes fade. Autodesk plunges on disappointing results. Eli Lilly rallies on an Alzheimer's study.
Will the biotech need to find a suitor after the halting of a once-promising development program?
JP Morgan, PetSmart and Eli Lilly are downgraded.
Stocks are mixed as Apple earnings weigh on the Nasdaq but improved outlooks from Boeing and Caterpillar support the Dow.
When mindless losers dump stocks in Europe-inspired sell-offs, you can pick up bargains.
The transaction also includes a $3.4 billion payment from AstraZeneca as the big drug companies try to replace lost sales from products with generic competition.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.